Municipal Employees Retirement System of Michigan lessened its stake in Hologic, Inc. (NASDAQ:HOLX) by 6.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,120 shares of the medical equipment provider’s stock after selling 1,690 shares during the quarter. Municipal Employees Retirement System of Michigan’s holdings in Hologic were worth $848,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the stock. Louisiana State Employees Retirement System grew its position in Hologic by 1.2% in the second quarter. Louisiana State Employees Retirement System now owns 17,400 shares of the medical equipment provider’s stock valued at $790,000 after acquiring an additional 200 shares during the last quarter. Aperio Group LLC grew its position in Hologic by 5.0% in the second quarter. Aperio Group LLC now owns 82,449 shares of the medical equipment provider’s stock valued at $3,742,000 after acquiring an additional 3,914 shares during the last quarter. Russell Investments Group Ltd. grew its position in Hologic by 229.7% in the second quarter. Russell Investments Group Ltd. now owns 1,059,586 shares of the medical equipment provider’s stock valued at $48,100,000 after acquiring an additional 738,215 shares during the last quarter. Acadian Asset Management LLC bought a new position in Hologic in the second quarter valued at about $1,648,000. Finally, ING Groep NV grew its position in Hologic by 0.7% in the second quarter. ING Groep NV now owns 60,750 shares of the medical equipment provider’s stock valued at $2,757,000 after acquiring an additional 406 shares during the last quarter. 97.72% of the stock is owned by institutional investors and hedge funds.
In related news, VP Karleen Marie Oberton sold 1,023 shares of the company’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $39.84, for a total value of $40,756.32. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Lawrence M. Levy sold 7,139 shares of the company’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $39.04, for a total value of $278,706.56. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 35,972 shares of company stock worth $1,385,977. Company insiders own 0.79% of the company’s stock.
HOLX has been the topic of a number of recent analyst reports. Needham & Company LLC reiterated a “buy” rating and issued a $50.00 target price on shares of Hologic in a research report on Monday, October 2nd. Deutsche Bank AG decreased their target price on Hologic from $51.00 to $49.00 and set a “buy” rating on the stock in a research report on Thursday, August 3rd. Goldman Sachs Group Inc cut Hologic from a “conviction-buy” rating to a “buy” rating and decreased their target price for the company from $48.00 to $47.00 in a research report on Thursday, August 3rd. Stifel Nicolaus reiterated a “buy” rating and issued a $45.00 target price (down previously from $48.00) on shares of Hologic in a research report on Monday, October 9th. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $44.00 target price (down previously from $49.00) on shares of Hologic in a research report on Tuesday, October 10th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $47.54.
Shares of Hologic, Inc. (HOLX) opened at $40.87 on Monday. The firm has a market capitalization of $11,267.20, a PE ratio of 20.23, a PEG ratio of 1.98 and a beta of 0.93. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.61 and a current ratio of 0.79. Hologic, Inc. has a twelve month low of $35.76 and a twelve month high of $46.80.
Hologic (NASDAQ:HOLX) last released its quarterly earnings results on Wednesday, November 8th. The medical equipment provider reported $0.50 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.49 by $0.01. The company had revenue of $802.90 million for the quarter, compared to analysts’ expectations of $792.54 million. Hologic had a return on equity of 21.69% and a net margin of 24.70%. The business’s quarterly revenue was up 10.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.52 earnings per share. research analysts anticipate that Hologic, Inc. will post 2.12 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This article was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://transcriptdaily.com/2017/11/27/municipal-employees-retirement-system-of-michigan-has-848000-position-in-hologic-inc-holx.html.
Hologic Company Profile
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).
Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.